Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 23532930)

1.

Vaccine delivery using nanoparticles.

Gregory AE, Titball R, Williamson D.

Front Cell Infect Microbiol. 2013 Mar 25;3:13. doi: 10.3389/fcimb.2013.00013. eCollection 2013. Review.

2.

Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.

Stano A, Nembrini C, Swartz MA, Hubbell JA, Simeoni E.

Vaccine. 2012 Dec 14;30(52):7541-6. doi: 10.1016/j.vaccine.2012.10.050. Epub 2012 Oct 25.

PMID:
23103199
3.

[Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine].

Akagi T, Baba M, Akashi M.

Yakugaku Zasshi. 2007 Feb;127(2):307-17. Review. Japanese.

4.

Improvement of different vaccine delivery systems for cancer therapy.

Bolhassani A, Safaiyan S, Rafati S.

Mol Cancer. 2011 Jan 7;10:3. doi: 10.1186/1476-4598-10-3. Review.

5.

Nanotechnology in vaccine delivery.

Peek LJ, Middaugh CR, Berkland C.

Adv Drug Deliv Rev. 2008 May 22;60(8):915-28. doi: 10.1016/j.addr.2007.05.017. Epub 2008 Feb 7. Review.

PMID:
18325628
6.

An overview of adjuvant formulations and delivery systems.

García A, De Sanctis JB.

APMIS. 2014 Apr;122(4):257-67. doi: 10.1111/apm.12143. Epub 2013 Aug 6. Review.

PMID:
23919674
7.

PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.

Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E.

Vaccine. 2011 Jan 17;29(4):804-12. doi: 10.1016/j.vaccine.2010.11.010. Epub 2010 Nov 19.

PMID:
21094269
8.

Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.

Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC.

Mol Pharm. 2012 Jan 1;9(1):81-90. doi: 10.1021/mp200264m. Epub 2011 Dec 16.

PMID:
22149016
9.

Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.

Badiee A, Heravi Shargh V, Khamesipour A, Jaafari MR.

Vaccine. 2013 Jan 21;31(5):735-49. doi: 10.1016/j.vaccine.2012.11.068. Epub 2012 Dec 7. Review.

PMID:
23219436
10.

Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.

Mohanan D, Slütter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, Kündig TM, Gander B, Johansen P.

J Control Release. 2010 Nov 1;147(3):342-9. doi: 10.1016/j.jconrel.2010.08.012. Epub 2010 Aug 18.

PMID:
20727926
11.

Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.

Zuckermann FA, Martin S, Husmann RJ, Brandt J.

Adv Vet Med. 1999;41:447-61. Review.

PMID:
9890035
12.

Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.

Mody KT, Popat A, Mahony D, Cavallaro AS, Yu C, Mitter N.

Nanoscale. 2013 Jun 21;5(12):5167-79. doi: 10.1039/c3nr00357d. Review.

PMID:
23657437
13.

C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c mice.

Doroud D, Zahedifard F, Vatanara A, Taslimi Y, Vahabpour R, Torkashvand F, Vaziri B, Rouholamini Najafabadi A, Rafati S.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1236. doi: 10.1371/journal.pntd.0001236. Epub 2011 Jul 12.

14.

Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.

Bolhassani A, Javanzad S, Saleh T, Hashemi M, Aghasadeghi MR, Sadat SM.

Hum Vaccin Immunother. 2014;10(2):321-32. doi: 10.4161/hv.26796. Epub 2013 Oct 15. Review.

15.

Recent developments in adjuvants for vaccines against infectious diseases.

O'Hagan DT, MacKichan ML, Singh M.

Biomol Eng. 2001 Oct 15;18(3):69-85. Review.

PMID:
11566599
16.

Liposomes and nanotechnology in drug development: focus on oncotargets.

Kozako T, Arima N, Yoshimitsu M, Honda SI, Soeda S.

Int J Nanomedicine. 2012;7:4943-51. doi: 10.2147/IJN.S30726. Epub 2012 Sep 14.

17.

Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.

Noh YW, Hong JH, Shim SM, Park HS, Bae HH, Ryu EK, Hwang JH, Lee CH, Cho SH, Sung MH, Poo H, Lim YT.

Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7684-9. doi: 10.1002/anie.201302881. Epub 2013 Jun 13.

PMID:
23765547
18.

Current status and potential application of ISCOMs in veterinary medicine.

Morein B, Hu KF, Abusugra I.

Adv Drug Deliv Rev. 2004 Jun 23;56(10):1367-82. Review.

PMID:
15191787
19.

Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.

Walcher P, Mayr UB, Azimpour-Tabrizi C, Eko FO, Jechlinger W, Mayrhofer P, Alefantis T, Mujer CV, DelVecchio VG, Lubitz W.

Expert Rev Vaccines. 2004 Dec;3(6):681-91. Review.

PMID:
15606353
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk